Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 18627948422 |
| E-mail: | sale@hdimpurity.com |
| QQ: | 3001016691 |
| Skype: | Chat Now! |
| Address: | Biwangxin Technology Building 503, Biwangxin High-tech Industrial Park, Xili Street, Nanshan District, Shenzhen |
|
ShenZhen H&D Pharmaceutical Technology Co., LTD is a professional supplier of pharmaceutical impurity control products. Short product delivery time, covering more than 90% of cutting-edge generic drug projects; All products must be checked for LCMS and HPLC within one year. We offer custom synthesis and preparation of small molecule compounds.
The company has its own research and development center, focusing on providing pharmaceutical research and development units with new drug and generic drug registration and application of chemical products, including drug standards, drug impurity reference products, characteristic intermediates, analytical testing and custom compound synthesis services. Our delivery standard is not less than 98% purity (HPLC).
The company focuses on providing pharmaceutical research and development units with new drug and generic drug registration applications and chemical products, including drug impurity reference products, standards, pharmaceutical intermediates, as well as drug impurity preparation, separation and purification business.
|
|
| Product Name | MF | CAS | Details |
|---|
| Dapoxetine impurity 29 | C15H14O | 1083-30-3 | Details |
| Dapoxetine impurity 70 | C10H8O | 90-15-3 | Details |
| Dapoxetine impurity 25 | C15H16O | 14097-24-6 | Details |
| Dapoxetine impurity 2 | C19H18O2 | 156453-50-8 | Details |
| Dapoxetine impurity 16 | Details |
| Lidocaine EP Impurity F | C14H22N2O | 142713-08-4 | Details |
| Dapoxetine impurity 17 | Details |
| Dapoxetine impurity 24 | C20H20O4S | 1445281-20-8 | Details |
| Fenofibrate EP Impurity G | C24H27ClO6 | 217636-48-1 | Details |
| Dapoxetine impurity 16 (Hydrochloride) | Details |
| Dapoxetine impurity 46 | C9H11NO2 | 13921-90-9 | Details |
| Dapoxetine Impurity 77 | C9H11ClO | 100306-34-1 | Details |
| Dapoxetine impurity 38 | C9H11NO2 | 40856-44-8 | Details |
| Dapoxetine impurity 3 (hydrochloride) | C21H24ClNO | 156453-51-9 | Details |
| Lidocaine EP Impurity J | C14H22N2O | 857570-37-7 | Details |
| Dapagliflozin Impurity E | C30H28Cl2O2 | 2176485-21-3 | Details |
| Lidocaine Impurity 29 | C18H22N2O | 294852-91-8 | Details |
| Dapagliflozin Impurity 21 | C21H25ClO6 | 2040305-05-1 | Details |
| Fenofibrate Impurity 1 | C17H16O5 | 61002-27-5 | Details |
| Dapoxetine impurity 47(Hydrochlorate) | Details |
| Lidocaine Impurity 4 | C11H16N2O | 42459-27-8 | Details |
| Lidocaine EP Impurity C | C10H13NO | 2198-53-0 | Details |
| Dapoxetine Impurity 79 | C9H12O | 1565-74-8 | Details |
| Tofacitinib Impurity 85 | C20H24ClN5 | 2268720-86-9 | Details |
| Dapoxetine Impurity 81 | C28H28O3 | 2415108-74-4 | Details |
| Lidocaine Impurity 27 | C12H18N2O | 21236-54-4 | Details |
| Dapoxetine impurity 3 | C21H23NO | 119357-36-7 | Details |
| Lidocaine Impurity 26 | C12H18N2O.ClH | 31785-64-5 | Details |
| Dapoxetine impurity 26 | Details |
| Dapoxetine impurity 41 | Details |
| Dapoxetine impurity 51 | Details |
| Dapoxetine impurity 45 | C28H26O2 | 2245197-11-7 | Details |
| Dapoxetine Impurity 85 | C10H11NO | 24241-74-5 | Details |
| Lidocaine Impurity 2 | C14H23ClN2O | 73-78-9 | Details |
| Dapoxetine Impurity 86 | C12H13N | 2436-85-3 | Details |
| Dapoxetine impurity 67 | Details |
| Fenofibrate EP Impurity E | C19H19ClO4 | 42019-08-9 | Details |
| Dapoxetine Impurity 72 | C17H19NO | 112068-01-6 | Details |
| Dapoxetine Impurity 48 | C19H19NO | 119357-34-5 | Details |
| Dapoxetine impurity 44 | C19H16O2 | 41198-42-9 | Details |
| Lidocaine EP Impurity D(Hydrochloride) | C12H19ClN2O | 7729-94-4 | Details |
| Dapagliflozin Impurity 8 | C15H12ClIO2 | 2305949-33-9 | Details |
| Dapoxetine Impurity 12 | C30H32ClNO2 | 2242008-38-2 | Details |
| Dapagliflozin Impurity 33 | Details |
| Tofacitinib Impurity 86 | Details |
| Tofacitinib Impurity 91 | Details |
| Dapoxetine impurity 4 | Details |
| Dapoxetine impurity 54 | Details |
| Dapoxetine impurity 14 (Hydrochloride) | Details |
| Dapoxetine Impurity 82(Hydrochloride) | Details |
| Dapoxetine Impurity 5 | C20H22ClNO | 157166-71-7 | Details |
| Dapoxetine impurity 28 | C9H10O2 | 501-52-0 | Details |
| Lidocaine EP Impurity G(Hydrochloride) | C13H21ClN2O | 35891-87-3 | Details |
| Lidocaine Impurity 11 | C20H26ClN3O2 | 1135231-62-7 | Details |
| Dapagliflozin Propanediol Hydrate | C24H33ClO8 | 960404-48-2 | Details |
| Dapoxetine impurity 52 | C9H9Cl | 21087-29-6 | Details |
| Lidocaine Impurity 28 | C20H22N2O2 | 70336-49-1 | Details |
| Dapagliflozin Impurity 55 | C7H3BrCl2O | 21900-52-7 | Details |
| Dapoxetine impurity 32 | Details |
| Dapoxetine impurity 6 | Details |
| Lidocaine Impurity 18 | C10H12ClNO | 39106-10-0 | Details |
| Dapoxetine Impurity 83 | Details |
| Lidocaine EP Impurity K(Hydrochloride) | C13H21ClN2O | 50295-20-0 | Details |
| Dapoxetine impurity 13 | C19H16O | 94305-25-6 | Details |
| Dapoxetine impurity 14 | C21H23NO2 | 1346603-24-4 | Details |
| Dapoxetine impurity 8 | C19H16O | 1091626-77-5 | Details |
| Lidocaine Impurity 3 | C11H16N2O.ClH | 35891-84-0 | Details |
| Dapoxetine Impurity 50 | C11H17N | 3330-05-0 | Details |
| Dapoxetine Impurity 76 | C10H10O | 529-34-0 | Details |
| Dapoxetine impurity 30 | C10H6O2 | 130-15-4 | Details |
| Dapoxetine impurity 43 | C28H26O3 | 2242008-36-0 | Details |
| Dapoxetine Impurity 84 | C19H16O | 149045-41-0 | Details |
| Dapoxetine Impurity 80 | C9H12O2 | 103548-16-9 | Details |
| Dapoxetine Impurity 87 | C10H6O2 | 613-20-7 | Details |
| Dapoxetine impurity 31 | C10H6O2 | 524-42-5 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| Dapagliflozin Impurity 6 | C21H25BrO6 | 1807632-95-6 | Details |
| Fenofibrate EP Impurity B | C17H15ClO4 | 42017-89-0 | Details |
| Fenofibrate Impurity 2 | C13H9ClO2 | 42019-78-3 | Details |
| Dapoxetine Impurity 75 | C30H31NO | 2245197-07-1 | Details |
| Tofacitinib Impurity 81 | Details |
| Tofacitinib Impurity 87 | Details |
| Tofacitinib Impurity 92 | Details |
| Dapagliflozin Impurity 9 | C15H14ClIO | 2305949-36-2 | Details |
| Fenofibrate Impurity 17 | Details |
| Lidocaine Impurity 14 | C10H12ClNO | 2564-07-0 | Details |
| Dapagliflozin | C21H25ClO6 | 461432-26-8 | Details |
| Fenofibrate EP Impurity C | C17H15ClO3 | 217636-47-0 | Details |
| Dapoxetine impurity 47 | C20H21NO | 119357-18-5 | Details |
| Dapoxetine impurity 15 | C19H18O2 | 908291-72-5 | Details |
| Lidocaine EP Impurity E | C20H25N3O2 | 745798-07-6 | Details |
| Dapagliflozin Impurity 3 | C19H21ClO6 | 864070-37-1 | Details |
| Dapoxetine impurity 21 | C9H9Cl | 2687-12-9 | Details |
| Dapoxetine impurity 37 | C9H9ClO | 936-59-4 | Details |
| Dapoxetine impurity 40 | C10H8O | 135-19-3 | Details |
| Dapoxetine impurity 42 | C11H10O3S | 38262-42-9 | Details |
| Dapoxetine impurity 33 | Details |
| Dapoxetine impurity 88 | C19H18O | 119357-48-1 | Details |
| Dapoxetine impurity 56 | Details |
| Lidocaine Impurity 23 | C10H12ClNO | 5177-35-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | ||||